Aegerion

CAMBRIDGE, Mass., 2016-03-31 09:00 CEST (GLOBE NEWSWIRE) — Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat debilitating rare diseases, announced today its observance of World Lipodystrophy Day. Chief Executive Officer Mary Szela said, „We support the Association of Families Affected by Lipodystrophies in Spain, Europe … Skaityti toliau